Here are three points:
1. The investment management firm now holds a total of 1.5 million NuVasive shares, valued at $79.7 million.
2. NuVasive reported total revenue of $215.1 million in first quarter of 2016, an 11.8 percent increase from the $192.4 million reported for the first quarter of 2015.
3. The company’s net loss reached $8.9 million for the first quarter 2016.
More articles on devices:
33 organizations implore Congress to postpone CMS equipment proposal: 5 things to know
Simplifying orthopedics in a complex industry — Dr. Joe Kohli changes the game with [m]pirik
InVivo Therapeutics shares mission on radio broadcast — 3 notes
